BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11153102)

  • 1. Involving minority and underrepresented women in clinical trials: the National Centers of Excellence in Women's Health.
    Killien M; Bigby JA; Champion V; Fernandez-Repollet E; Jackson RD; Kagawa-Singer M; Kidd K; Naughton MJ; Prout M
    J Womens Health Gend Based Med; 2000 Dec; 9(10):1061-70. PubMed ID: 11153102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Women's health centers and minority women: addressing barriers to care. The National Centers of Excellence in Women's Health.
    Jackson S; Camacho D; Freund KM; Bigby J; Walcott-McQuigg J; Hughes E; Nunez A; Dillard W; Weiner C; Weitz T; Zerr A
    J Womens Health Gend Based Med; 2001; 10(6):551-9. PubMed ID: 11559452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recruitment and retention of minority women in cancer screening, prevention, and treatment trials.
    Brown DR; Fouad MN; Basen-Engquist K; Tortolero-Luna G
    Ann Epidemiol; 2000 Nov; 10(8 Suppl):S13-21. PubMed ID: 11189088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hispanic research: implications of the National Institutes of Health guidelines on inclusion of women and minorities in clinical research.
    Caban CE
    J Natl Cancer Inst Monogr; 1995; (18):165-9. PubMed ID: 8562217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying and caring for underserved populations: experience of the National Centers of Excellence in Women's Health.
    Weitz TA; Freund KM; Wright L
    J Womens Health Gend Based Med; 2001 Dec; 10(10):937-52. PubMed ID: 11788105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minority recruitment and participation in health research.
    Corbie-Smith GM
    N C Med J; 2004; 65(6):385-7. PubMed ID: 15714732
    [No Abstract]   [Full Text] [Related]  

  • 7. Participation of women in clinical trials of drug therapies: a context for the controversies.
    Prout MN; Fish SS
    Medscape Womens Health; 2001 Oct; 6(5):1. PubMed ID: 11698923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Setting a local research agenda for women's health: The National Centers of Excellence in Women's Health.
    Mosca L; Allen C; Fernandez-Repollet E; Kim C; Lee M; McAuley JW; McLaughlin M;
    J Womens Health Gend Based Med; 2001 Dec; 10(10):927-35. PubMed ID: 11788104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why should we include women and minorities in randomized controlled trials?
    Weijer C; Crouch RA
    J Clin Ethics; 1999; 10(2):100-6. PubMed ID: 10633280
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV/AIDS: a minority health issue.
    Cargill VA; Stone VE
    Med Clin North Am; 2005 Jul; 89(4):895-912. PubMed ID: 15925655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoting the advancement of minority women faculty in academic medicine: the National Centers of Excellence in Women's Health.
    Wong EY; Bigby J; Kleinpeter M; Mitchell J; Camacho D; Dan A; Sarto G
    J Womens Health Gend Based Med; 2001; 10(6):541-50. PubMed ID: 11559451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using women's health research to develop women leaders in academic health sciences: the National Centers of Excellence in Women's Health.
    Carnes M; VandenBosche G; Agatisa PK; Hirshfield A; Dan A; Shaver JL; Murasko D; McLaughlin M
    J Womens Health Gend Based Med; 2001; 10(1):39-47. PubMed ID: 11224943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers and facilitators to participation of minorities in clinical trials.
    Schmotzer GL
    Ethn Dis; 2012; 22(2):226-30. PubMed ID: 22764647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enrollment of racial/ethnic minorities and women with HIV in clinical research studies of HIV medicines.
    Sullivan PS; McNaghten AD; Begley E; Hutchinson A; Cargill VA
    J Natl Med Assoc; 2007 Mar; 99(3):242-50. PubMed ID: 17393948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to federal guidelines for reporting of sex and race/ethnicity in clinical trials.
    Geller SE; Adams MG; Carnes M
    J Womens Health (Larchmt); 2006 Dec; 15(10):1123-31. PubMed ID: 17199453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing participation of women in early phase clinical trials approved by the FDA.
    Pinnow E; Sharma P; Parekh A; Gevorkian N; Uhl K
    Womens Health Issues; 2009; 19(2):89-93. PubMed ID: 19272558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Working Together to Address Women's Health in Research and Drug Development: Summary of the 2017 Women's Health Congress Preconference Symposium.
    Feuerstein IM; Jenkins MR; Kornstein SG; Lauer MS; Scott PE; Raju TNK; Johnson T; Devaney S; Lolic M; Henderson M; Clayton JA
    J Womens Health (Larchmt); 2018 Oct; 27(10):1195-1203. PubMed ID: 30325292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Special populations recruitment for the Women's Health Initiative: successes and limitations.
    Fouad MN; Corbie-Smith G; Curb D; Howard BV; Mouton C; Simon M; Talavera G; Thompson J; Wang CY; White C; Young R
    Control Clin Trials; 2004 Aug; 25(4):335-52. PubMed ID: 15296809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation in clinical trials among women living with HIV in Canada. Canadian Women's HIV Study Group.
    Hankins C; Lapointe N; Walmsley S
    CMAJ; 1998 Dec; 159(11):1359-65. PubMed ID: 9861204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women's health research: policy and practice.
    Ickovics JR; Epel ES
    IRB; 1993; 15(4):1-7. PubMed ID: 11652149
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.